Comparison between Citichem India IPO and Davin Sons Retail IPO.
Citichem India IPO is a SME Fixed Price IPO proposed to list at BSE SME while Davin Sons Retail IPO is a SME Fixed Price proposed to list at BSE SME.
| Citichem India IPO | Davin Sons Retail IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Horizon Management Pvt.Ltd. | Navigant Corporate Advisors Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Aftertrade Broking Pvt.Ltd. | Aftertrade Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Citichem India IPO is up to ₹11.96 Cr whereas the issue size of the Davin Sons Retail IPO is up to ₹8.34 Cr. The final issue price of Citichem India IPO is ₹70.00 per share and of Davin Sons Retail IPO is ₹55.00 per share.
| Citichem India IPO | Davin Sons Retail IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹55.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 17,08,000 shares | 15,16,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.96 Cr | up to ₹8.34 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,08,000 shares | 15,16,000 shares |
| Issue Size Total (Amount) | up to ₹11.96 Cr | up to ₹8.34 Cr |
Citichem India IPO opens on Dec 27, 2024, while Davin Sons Retail IPO opens on Jan 02, 2025. The closing date of Citichem India IPO and Davin Sons Retail IPO is Dec 31, 2024, and Jan 06, 2025, respectively.
| Citichem India IPO | Davin Sons Retail IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 27, 2024 | Jan 02, 2025 |
| Issue Close | Dec 31, 2024 | Jan 06, 2025 |
| Basis Of Allotment (Tentative) | Jan 01, 2025 | Jan 07, 2025 |
| Initiation of Refunds (Tentative) | Jan 02, 2025 | Jan 08, 2025 |
| Credit of Share (Tentative) | Jan 02, 2025 | Jan 08, 2025 |
| Listing date (Tentative) | Jan 03, 2025 | Jan 09, 2025 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Citichem India IPO P/E ratio is 31.3, as compared to Davin Sons Retail IPO P/E ratio of 12.29.
| Citichem India IPO | Davin Sons Retail IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Citichem India Limited Financial Information (Restated)Citichem India Limited's revenue decreased by -6% and profit after tax (PAT) rose by 208% between the financial year ending with March 31, 2024 and March 31, 2023.
| Davin Sons Retail Limited Financial Information (Restated Consolidated)Davin Sons Retail Limited's revenue increased by 242% and profit after tax (PAT) rose by 190% between the financial year ending with March 31, 2024 and March 31, 2023.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.25 | 90.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.21 | 63.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 31.3 | 12.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹47.60 Cr. | ₹28.95 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15.42% | 49.41% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.47% | 54.52% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.24 | ₹4.47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.42% | 29.58% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Citichem India IPO Retail Individual Investors (RII) are offered 8,54,000 shares while in Davin Sons Retail IPO retail investors are offered 8,54,000 shares. Qualified Institutional Buyers (QIB) are offered in Citichem India IPO and 0 shares in Davin Sons Retail IPO.
| Citichem India IPO | Davin Sons Retail IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | |
| Market Maker Reserveration | 92,000 shares | 80,000 shares |
| QIB | 0 shares | |
| NII | 8,54,000 shares | 7,58,000 shares |
| RII | 8,54,000 shares | 7,58,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 17,08,000 shares | 15,16,000 shares |
Citichem India IPO subscribed 414.35x in total, whereas Davin Sons Retail IPO subscribed 120.80x.
| Citichem India IPO | Davin Sons Retail IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 277.88x | 66.10x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 543.18x | 164.78x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 414.35x | 120.80x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
